Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IPR-15006269Phase 4Not yet recruiting
Phase 4, randomised, open-label trial in gout comparing Prednisolone group, Etoricoxib group and Indomethacin group (3 arms). Primary endpoint: Joint pain intensity. Planned start Apr 2015; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IPR-15006269.